Ad is loading...
CBLSX
Price
$14.27
Change
+$0.12 (+0.85%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

CBLSX vs VVIAX

Header iconCBLSX vs VVIAX Comparison
Open Charts CBLSX vs VVIAXBanner chart's image
Allspring Large Cap Value Inst
Price$14.27
Change+$0.12 (+0.85%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
CBLSX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBLSX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBLSX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. CBLSX (183M). VVIAX pays higher dividends than CBLSX: VVIAX (2.36) vs CBLSX (1.44). CBLSX was incepted earlier than VVIAX: CBLSX (20 years) vs VVIAX (24 years). CBLSX is a more actively managed with annual turnover of: 29.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than CBLSX: VVIAX (3000) vs CBLSX (1000000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. CBLSX (16.20). VVIAX return over 5 years is better than : 53.09 vs. CBLSX (-2.10).
CBLSXVVIAXCBLSX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD19.21519.67298%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets183M184B0%
Annual Yield % from dividends1.442.3661%
Returns for 1 year16.2026.0962%
Returns for 3 years-15.6824.77-63%
Returns for 5 years-2.1053.09-4%
Returns for 10 years22.11112.2620%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics